Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
grade A 45.105 -0.36% -0.17
NVCR closed up 0.02 percent on Thursday, January 17, 2019, on 1.43 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NVCR trend table...

Date Alert Name Type % Chg
Jan 17 NR7 Range Contraction -0.36%
Jan 17 NR7-2 Range Contraction -0.36%
Jan 17 Wide Bands Range Expansion -0.36%
Jan 17 Overbought Stochastic Strength -0.36%
Jan 17 Up 3 Days in a Row Strength -0.36%
Jan 16 New Uptrend Bullish -0.34%
Jan 16 Pocket Pivot Bullish Swing Setup -0.34%
Jan 16 NR7 Range Contraction -0.34%
Jan 16 Upper Bollinger Band Walk Strength -0.34%
Jan 16 Wide Bands Range Expansion -0.34%

Older signals for NVCR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Is NVCR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 53.7
52 Week Low 19.2
Average Volume 711,902
200-Day Moving Average 35.1246
50-Day Moving Average 34.1626
20-Day Moving Average 36.3795
10-Day Moving Average 40.909
Average True Range 1.9583
ADX 27.84
+DI 40.2992
-DI 12.9665
Chandelier Exit (Long, 3 ATRs ) 39.8351
Chandelier Exit (Short, 3 ATRs ) 34.7049
Upper Bollinger Band 47.2364
Lower Bollinger Band 25.5226
Percent B (%b) 0.91
BandWidth 59.686912
MACD Line 2.9902
MACD Signal Line 1.7524
MACD Histogram 1.2378
Fundamentals Value
Market Cap 4.03 Billion
Num Shares 88.9 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -41.53
Price-to-Sales 13.08
Price-to-Book 13.88
PEG Ratio -0.41
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.95
Resistance 3 (R3) 46.91 46.31 46.67
Resistance 2 (R2) 46.31 45.88 46.33 46.58
Resistance 1 (R1) 45.79 45.62 46.05 45.83 46.48
Pivot Point 45.19 45.19 45.32 45.21 45.19
Support 1 (S1) 44.67 44.76 44.93 44.71 44.06
Support 2 (S2) 44.07 44.50 44.09 43.96
Support 3 (S3) 43.55 44.07 43.87
Support 4 (S4) 43.59